Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 994

1.

EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer.

Gemoll T, Kollbeck SL, Karstens KF, Hò GG, Hartwig S, Strohkamp S, Schillo K, Thorns C, Oberländer M, Kalies K, Lehr S, Habermann JK.

Oncotarget. 2017 Jul 4;8(33):54939-54950. doi: 10.18632/oncotarget.18978. eCollection 2017 Aug 15.

PMID:
28903393
2.

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.

Kamel HFM, Al-Amodi HSAB.

Genomics Proteomics Bioinformatics. 2017 Aug;15(4):220-235. doi: 10.1016/j.gpb.2016.11.005. Epub 2017 Aug 13. Review.

3.

Use of endocytoscopy for identification of sessile serrated adenoma/polyps and hyperplastic polyps by quantitative image analysis of the luminal areas.

Ogawa Y, Kudo SE, Mori Y, Ikehara N, Maeda Y, Wakamura K, Misawa M, Kudo T, Hayashi T, Miyachi H, Katagiri A, Ishida F, Inoue H.

Endosc Int Open. 2017 Aug;5(8):E769-E774. doi: 10.1055/s-0043-113562. Epub 2017 Aug 7.

4.

Variable selection for disease progression models: methods for oncogenetic trees and application to cancer and HIV.

Hainke K, Szugat S, Fried R, Rahnenführer J.

BMC Bioinformatics. 2017 Aug 1;18(1):358. doi: 10.1186/s12859-017-1762-1.

5.

Sociodemographic characteristics of nonparticipants in the Danish colorectal cancer screening program: a nationwide cross-sectional study.

Larsen MB, Mikkelsen EM, Rasmussen M, Friis-Hansen L, Ovesen AU, Rahr HB, Andersen B.

Clin Epidemiol. 2017 Jun 27;9:345-354. doi: 10.2147/CLEP.S139168. eCollection 2017.

6.

Genetic alterations in Japanese extrahepatic biliary tract cancer.

Noguchi R, Yamaguchi K, Ikenoue T, Terakado Y, Ohta Y, Yamashita N, Kainuma O, Yokoi S, Maru Y, Nagase H, Furukawa Y.

Oncol Lett. 2017 Jul;14(1):877-884. doi: 10.3892/ol.2017.6224. Epub 2017 May 22.

7.

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis.

Yamashina T, Fukuhara M, Maruo T, Tanke G, Marui S, Sada R, Taki M, Ohara Y, Sakamoto A, Henmi S, Sawai Y, Saito S, Nishijima N, Nasu A, Komekado H, Sekikawa A, Asada M, Tumura T, Kita R, Kimura T, Osaki Y.

Endosc Int Open. 2017 Jul;5(7):E587-E594. doi: 10.1055/s-0043-105578. Epub 2017 Jun 23.

8.

Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?

Kim NH, Park JH, Park DI, Sohn CI, Jung YS.

J Korean Med Sci. 2017 Aug;32(8):1281-1287. doi: 10.3346/jkms.2017.32.8.1281.

9.

K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Margetis N, Kouloukoussa M, Pavlou K, Vrakas S, Mariolis-Sapsakos T.

In Vivo. 2017 Jul-Aug;31(4):527-542. Review.

10.

BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis.

Li Y, Li W.

Saudi J Gastroenterol. 2017 May-Jun;23(3):144-149. doi: 10.4103/1319-3767.207712. Review.

11.

Linked color imaging improves the visibility of colorectal polyps: a video study.

Yoshida N, Naito Y, Murakami T, Hirose R, Ogiso K, Inada Y, Dohi O, Kamada K, Uchiyama K, Handa O, Konishi H, Siah KTH, Yagi N, Fujita Y, Kishimoto M, Yanagisawa A, Itoh Y.

Endosc Int Open. 2017 Jun;5(6):E518-E525. doi: 10.1055/s-0043-105495. Epub 2017 Jun 7.

12.

The genomic road to invasion-examining the similarities and differences in the genomes of associated oral pre-cancer and cancer samples.

Wood HM, Daly C, Chalkley R, Senguven B, Ross L, Egan P, Chengot P, Graham J, Sethi N, Ong TK, MacLennan K, Rabbitts P, Conway C.

Genome Med. 2017 Jun 7;9(1):53. doi: 10.1186/s13073-017-0442-0.

13.

Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.

Sugai T, Yoshida M, Eizuka M, Uesugii N, Habano W, Otsuka K, Sasaki A, Yamamoto E, Matsumoto T, Suzuki H.

Clin Epigenetics. 2017 May 18;9:55. doi: 10.1186/s13148-017-0352-4. eCollection 2017.

14.

Immunotherapy for Colorectal Cancer.

Boland PM, Ma WW.

Cancers (Basel). 2017 May 11;9(5). pii: E50. doi: 10.3390/cancers9050050. Review.

15.

Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer.

Iijima M, Banno K, Okawa R, Yanokura M, Iida M, Takeda T, Kunitomi-Irie H, Adachi M, Nakamura K, Umene K, Nogami Y, Masuda K, Tominaga E, Aoki D.

Oncol Lett. 2017 Mar;13(3):1063-1070. doi: 10.3892/ol.2017.5582. Epub 2017 Jan 10.

16.

British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.

East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ.

Gut. 2017 Jul;66(7):1181-1196. doi: 10.1136/gutjnl-2017-314005. Epub 2017 Apr 27. Review.

17.

Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.

Guo Y, Bao Y, Yang W.

Int J Mol Sci. 2017 Apr 22;18(4). pii: E890. doi: 10.3390/ijms18040890. Review.

18.

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.

Korphaisarn K, Morris VK, Overman MJ, Fogelman DR, Kee BK, Raghav KPS, Manuel S, Shureiqi I, Wolff RA, Eng C, Menter D, Hamilton SR, Kopetz S, Dasari A.

Oncotarget. 2017 Jun 13;8(24):39268-39279. doi: 10.18632/oncotarget.16848.

19.

Findings in young adults at colonoscopy from a hospital service database audit.

Wong S, Lidums I, Rosty C, Ruszkiewicz A, Parry S, Win AK, Tomita Y, Vatandoust S, Townsend A, Patel D, Hardingham JE, Roder D, Smith E, Drew P, Marker J, Uylaki W, Hewett P, Worthley DL, Symonds E, Young GP, Price TJ, Young JP.

BMC Gastroenterol. 2017 Apr 19;17(1):56. doi: 10.1186/s12876-017-0612-y.

20.

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.

Jia X, Shanmugam C, Paluri RK, Jhala NC, Behring MP, Katkoori VR, Sugandha SP, Bae S, Samuel T, Manne U.

Oncotarget. 2017 Mar 21;8(12):20198-20212. doi: 10.18632/oncotarget.15560.

Supplemental Content

Support Center